Phosphodiesterase inhibitor and selective serotonin reuptake inhibitor combination therapy versus monotherapy for the treatment of major depressive disorder: a systematic review and meta-analysis
Author:
Affiliation:
1. College of Medicine and Life Sciences, University of Toledo, Toledo, Ohio
2. Division of Gastroenterology & Hepatology, Indiana University, Indianapolis, Indiana
3. Department of Psychiatry, University of Toledo, Toledo, Ohio, USA
Abstract
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Psychiatry and Mental health
Reference32 articles.
1. Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder.;Abdallah;CNS Neurosci Ther,2021
2. Is phosphodiesterase inhibition a new mechanism of antidepressant action? A double blind double-dummy study between rolipram and desipramine in hospitalized major and/or endogenous depressives.;Bobon;Eur Arch Psychiatry Neurol Sci,1988
3. Phosphodiesterase-5 inhibitors: shedding new light on the darkness of depression?;Duarte-Silva;J Affect Disord,2020
4. What is new about new antidepressants?;Dubovsky;Psychother Psychosom,2018
5. The phosphodiesterase inhibitor pentoxifylline as a novel adjunct to antidepressants in major depressive disorder patients: a proof-of-concept, randomized, double-blind, placebo-controlled trial.;El-Haggar;Psychother Psychosom,2018
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mobilization of the innate immune response by a specific immunostimulant β-glucan confers resistance to chronic stress-induced depression-like behavior by preventing neuroinflammatory responses;International Immunopharmacology;2024-01
2. Sildenafil and depression: True or false prophecy;CNS Neuroscience & Therapeutics;2023-07-14
3. Erectile dysfunction drugs are essential and probably life-saving and should be provided to all men who need them just as birth control should be provided to all women who need them;International Journal of Impotence Research;2023-07-13
4. Debated issues in major psychoses;International Clinical Psychopharmacology;2023-05-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3